Azolo triazines and pyrimidines
US7678793B2 · kind B2 · utility
2Cited by
23References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2006 |
| Grant date | Mar 16, 2010 |
| Priority date | — |
| Expiry date | Jan 11, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Corticotropin releasing factor (CRF) antagonists of formula I or II:and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.